Physician profile
Randolph C Bishop
NPI 1659360600
$169,836.79
in general payments reported to CMS, 2019-2025
39 companies · $2,290 in 2025
The $2,290 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162K · 2020: $524 · 2021: $834 · 2022: $1,745 · 2023: $526 · 2024: $1,719 · 2025: $2,290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,186 · Travel and Lodging: $1,348 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,186.41 |
| Travel and Lodging | $1,348.31 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amendia, INC. | $161,848.31 | 2019 | |
| Medtronic, INC. | $1,883.40 | 2021-2025 | Mazor X System, Inceptiv |
| Boston Scientific Corporation | $1,467.10 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $1,163.34 | 2020-2025 | Proclaim |
| Intelivation Technologies, LLC | $1,000.00 | 2024 | |
| Spinal Elements, INC. | $274.31 | 2022 | |
| Kyocera Medical Technologies, INC. | $182.20 | 2022-2024 | |
| Collegium Pharmaceutical, INC. | $173.17 | 2021-2024 | Nucynta, Belbuca |
| Abbvie INC. | $168.00 | 2021-2024 | |
| Globus Medical, INC. | $151.83 | 2025 | Senza |
| Nevro Corp. | $148.74 | 2019-2024 | Senza |
| Medtronic USA, INC. | $137.88 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119.47 | 2020-2024 | Relistor |
| Spinal Simplicity, LLC | $113.29 | 2022-2024 | Ha Minuteman G3-R |
| Biohaven Pharmaceutical Holding Company LTD. | $98.80 | 2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randolph Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.